{"abstract": "The hedge fund Pershing Square, owner of nearly 10 percent of Allergan shares, has led the charge to call the special meeting, at which Allergan shareholders could vote to replace a majority of the board, paving the way for a merger with Valeant Pharmaceuticals.", "web_url": "https://dealbook.nytimes.com/2014/08/22/valeant-and-pershing-square-said-to-have-votes-for-special-meeting-of-botox-maker-allergan/", "snippet": "The hedge fund Pershing Square, owner of nearly 10 percent of Allergan shares, has led the charge to call the special meeting, at which Allergan shareholders could vote to replace a majority of the board, paving the way for a merger with Valeant P...", "lead_paragraph": "Updated, 6:44 p.m. | ", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-articleLarge.jpg", "height": 400, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 400}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-jumbo.jpg", "height": 682, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-superJumbo.jpg", "height": 979, "width": 1469, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Valeant and Pershing Square Say They Have Votes for Special Meeting of Botox Maker Allergan", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Botox (Drug)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "organizations", "value": "ALLERGAN INC", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": 5, "major": "N"}], "pub_date": "2014-08-22T21:45:32+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By David Gelles", "person": [{"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/1769f3d7-4d1f-5b88-b245-b5588ae3f7c0", "word_count": 459, "uri": "nyt://article/1769f3d7-4d1f-5b88-b245-b5588ae3f7c0"}